PRIA Logo™
HR7867119th CongressWALLET

Infant Formula Safety Modernization Act of 2026

Sponsored By: Representative DeLauro, Rosa L. [D-CT-3]

Introduced

Summary

Standardized pathogen testing for infant formula would require routine testing of both products and manufacturing environments and speed up reporting to regulators and Congress. The bill would set which pathogens to test for, name Clostridium botulinum, define environmental "Zone 2" and "Zone 3" areas, and force clearer, uniform inspection standards.

Show full summary
  • Families and caregivers: Would increase testing of finished infant formula and facility environments and require faster reporting of positive results, improving transparency about contamination risks.
  • Manufacturers: Would require updates to Good Manufacturing Practices, environmental testing in Zones 2 and 3, and retention of positive-test records for inspection purposes.
  • FDA and Congress: Would direct the FDA Commissioner to set consistent inspection and compliance rules for all infant formula regardless of origin and require written notice to specified congressional committees within one business day after positive finished-product tests or an "official action indicated" inspection classification.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 0 benefits, 0 costs, 1 mixed.

Stricter infant formula safety rules

If enacted, the FDA would have 90 days to issue final rules updating infant formula manufacturing and product testing. The rules would require testing of both factories and finished formula for listed pathogens, including Clostridium botulinum. The rules would require environmental testing in defined Zone 2 and Zone 3 areas and set inspection standards the same for all formula, no matter where it is made. Infant formula makers would have to send the FDA written notice within one business day of any positive test for listed pathogens and keep records for inspections. The FDA would have to notify four congressional committees in writing within one business day after a positive finished-product test or after an 'official action indicated' inspection classification.

Sponsors & CoSponsors

Sponsor

DeLauro, Rosa L. [D-CT-3]

CT • D

Cosponsors

  • Rep. Grijalva, Adelita S. [D-AZ-7]

    AZ • D

    Sponsored 3/9/2026

  • Rep. Panetta, Jimmy [D-CA-19]

    CA • D

    Sponsored 3/9/2026

  • Rep. Jacobs, Sara [D-CA-51]

    CA • D

    Sponsored 3/9/2026

  • Del. Norton, Eleanor Holmes [D-DC-At Large]

    DC • D

    Sponsored 3/9/2026

  • Rep. Wilson, Frederica S. [D-FL-24]

    FL • D

    Sponsored 3/9/2026

  • Rep. Bishop, Sanford D. [D-GA-2]

    GA • D

    Sponsored 3/9/2026

  • Rep. Williams, Nikema [D-GA-5]

    GA • D

    Sponsored 3/9/2026

  • Rep. Pappas, Chris [D-NH-1]

    NH • D

    Sponsored 3/9/2026

  • Rep. Quigley, Mike [D-IL-5]

    IL • D

    Sponsored 3/9/2026

  • Rep. Krishnamoorthi, Raja [D-IL-8]

    IL • D

    Sponsored 3/9/2026

  • Rep. Schakowsky, Janice D. [D-IL-9]

    IL • D

    Sponsored 3/9/2026

  • Rep. Tlaib, Rashida [D-MI-12]

    MI • D

    Sponsored 3/9/2026

  • Rep. Thanedar, Shri [D-MI-13]

    MI • D

    Sponsored 3/9/2026

  • Rep. Ross, Deborah K. [D-NC-2]

    NC • D

    Sponsored 3/9/2026

  • Rep. Van Drew, Jefferson [R-NJ-2]

    NJ • R

    Sponsored 3/9/2026

  • Rep. Dean, Madeleine [D-PA-4]

    PA • D

    Sponsored 3/9/2026

  • Rep. Cohen, Steve [D-TN-9]

    TN • D

    Sponsored 3/9/2026

  • Rep. Meng, Grace [D-NY-6]

    NY • D

    Sponsored 3/18/2026

  • Rep. Carson, André [D-IN-7]

    IN • D

    Sponsored 4/13/2026

  • Rep. Magaziner, Seth [D-RI-2]

    RI • D

    Sponsored 4/20/2026

  • Rep. Pressley, Ayanna [D-MA-7]

    MA • D

    Sponsored 4/27/2026

  • Rep. Trahan, Lori [D-MA-3]

    MA • D

    Sponsored 5/12/2026

  • Rep. Brownley, Julia [D-CA-26]

    CA • D

    Sponsored 5/12/2026

  • Rep. Stansbury, Melanie A. [D-NM-1]

    NM • D

    Sponsored 5/20/2026

  • Rep. García, Jesús G. "Chuy" [D-IL-4]

    IL • D

    Sponsored 5/20/2026

  • Rep. Lawler, Michael [R-NY-17]

    NY • R

    Sponsored 6/22/2026

  • Rep. Moulton, Seth [D-MA-6]

    MA • D

    Sponsored 6/22/2026

  • Rep. Wasserman Schultz, Debbie [D-FL-25]

    FL • D

    Sponsored 7/13/2026

  • Rep. Lieu, Ted [D-CA-36]

    CA • D

    Sponsored 7/16/2026

  • Rep. Bonamici, Suzanne [D-OR-1]

    OR • D

    Sponsored 7/16/2026

  • Rep. McIver, LaMonica [D-NJ-10]

    NJ • D

    Sponsored 7/20/2026

  • Rep. Jackson, Jonathan L. [D-IL-1]

    IL • D

    Sponsored 7/21/2026

  • Rep. Landsman, Greg [D-OH-1]

    OH • D

    Sponsored 7/21/2026

  • Rep. Davis, Danny K. [D-IL-7]

    IL • D

    Sponsored 7/21/2026

  • Rep. Leger Fernandez, Teresa [D-NM-3]

    NM • D

    Sponsored 7/21/2026

  • Rep. Raskin, Jamie [D-MD-8]

    MD • D

    Sponsored 7/21/2026

  • Rep. McCollum, Betty [D-MN-4]

    MN • D

    Sponsored 7/22/2026

  • Rep. Kelly, Robin L. [D-IL-2]

    IL • D

    Sponsored 7/22/2026

  • Rep. Elfreth, Sarah [D-MD-3]

    MD • D

    Sponsored 8/24/2026

  • Rep. Vindman, Eugene Simon [D-VA-7]

    VA • D

    Sponsored 8/24/2026

  • Rep. Johnson, Henry C. "Hank" [D-GA-4]

    GA • D

    Sponsored 8/24/2026

  • Rep. DelBene, Suzan K. [D-WA-1]

    WA • D

    Sponsored 8/24/2026

  • Rep. Moore, Riley M. [R-WV-2]

    WV • R

    Sponsored 8/24/2026

  • Rep. Fitzpatrick, Brian K. [R-PA-1]

    PA • R

    Sponsored 9/10/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation